These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 676865)

  • 1. Secondary prevention and associated drug therapy.
    Donat K
    Adv Cardiol; 1978; (24):84-93. PubMed ID: 676865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary prevention in coronary patients after inpation rehabilitation].
    Völler H; Klein G; Gohlke H; Dovifat C; Binting S; Müller-Nordhorn J; Willich SN;
    Dtsch Med Wochenschr; 2000 Dec; 125(48):1457-61. PubMed ID: 11153414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac rehabilitation and secondary prevention of coronary heart disease.
    Ades PA
    N Engl J Med; 2001 Sep; 345(12):892-902. PubMed ID: 11565523
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of smoking cessation, physical training and psychological interventions in secondary prevention of coronary heart disease].
    Jost S
    Z Kardiol; 1994 Oct; 83(10):742-58. PubMed ID: 7810188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prescription habits in the long-term treatment with digitalis glycosides].
    Koenig WF
    Dtsch Med Wochenschr; 1983 Nov; 108(45):1716-8. PubMed ID: 6628253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical activity in the cardiac patient.
    Sellier P
    J Cardiovasc Pharmacol; 1995; 25 Suppl 1():S9-14. PubMed ID: 7752669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications during physical rehabilitation of coronary patients, with comments on drug therapy.
    Hakkila J
    G Ital Cardiol; 1973 May; 3(5):632-6. PubMed ID: 4149180
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of inpatient rehabilitation on cardiovascular risk factors in patients with coronary heart disease. PIN-Study Group].
    Völler H; Hahmann H; Gohlke H; Klein G; Rombeck B; Binting S; Willich SN
    Dtsch Med Wochenschr; 1999 Jul; 124(27):817-23. PubMed ID: 10432941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of digitalis in patients with coronary artery disease.
    Gheorghiade M; Beller GA
    Cardiol Clin; 1984 Feb; 2(1):135-46. PubMed ID: 6399999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary prevention after myocardial infarction in the aged (author's transl)].
    Michel D
    Aktuelle Gerontol; 1982 Jul; 12(4):149-54. PubMed ID: 6126140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers, plasma lipids, and coronary heart disease.
    Cruickshank JM
    Circulation; 1990 Sep; 82(3 Suppl):II60-5. PubMed ID: 1975524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Type 2 diabetes mellitus and coronary heart disease].
    Brändle M; Amann FW; Salomon F
    Schweiz Med Wochenschr; 1999 May; 129(18):700-6. PubMed ID: 10407943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of sudden death in ischemic heart disease].
    Tsolov Ts
    Vutr Boles; 1980; 19(6):14-21. PubMed ID: 6111160
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug-support of active therapy for rehabilitation in coronary insufficiency].
    Schleusing G
    Z Gesamte Inn Med; 1970 Aug; 25(15):680-5. PubMed ID: 5005761
    [No Abstract]   [Full Text] [Related]  

  • 19. [Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998].
    Jenni D; Osterwalder R; Osswald S; Buser P; Pfisterer M
    Praxis (Bern 1994); 2001 Oct; 90(41):1759-65. PubMed ID: 11692790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-tocopherol supplementation for men with existing coronary artery disease: a feasibility study.
    Hoffman RM; Garewal HS
    Prev Med; 1999 Aug; 29(2):112-8. PubMed ID: 10446037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.